Acumen Pharmaceuticals (ABOS) Competitor Comparison
We are evaluating the key criteria listed to compare Acumen Pharmaceuticals (ABOS) against its competitors in the Biotechnology industry.
Market Capitalization
216 / 368Gross Profits
181 / 278Total Revenue
0 / 300EBITDA
147 / 337Free Cashflow
173 / 352Quick Ratio
8 / 357Earnings per Share
143 / 359Dividend yield
0 / 6Total Cash
148 / 358Performance 3 years
220 / 368Performance 5 years
291 / 368Performance 10 years
258 / 368Linearity 3 years
138 / 368Linearity 5 years
286 / 368Linearity 10 years
245 / 367Total Rank
282 / 368Dividend Rank
328 / 368Valuation Rank
336 / 368Piotroski Rank
146 / 368Muliplier Rank
251 / 368Market Capitalization - ABOS ranking 216 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.